糠酸莫米松市場:各劑型，各適應症，各給藥途徑，各流通管道，各地區- 規模，佔有率，展望，機會分析，2022年～2030年

Mometasone Furoate Market, by Dosage Form, by Indication, by Route Of Administration, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

出版日期: 2022年09月02日 | 出版商:

Coherent Market Insights | 英文 193 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

市場動態

由於全球哮喘患病率上升，預計在預測期內將出現顯著增長。

本調查的主要特徵

本報告提供以2021年為基準年的預測期間（2022-2030 年）之全球糠酸莫米松市場的市場規模和復合年增長率（CAGR %）相關的詳細分析。
並闡明不同部門市場的潛在收入機會，說明該市場具有魅力的投資主張矩陣。
同時並提供市場推動因素和限制、機會、新產品發布或批准、市場趨勢、區域前景和主要參與者採用的競爭戰略等重要考察。
並基於企業亮點，各類型投資組合、主要焦點、財務業績和市場策略等參數，介紹全球糠酸莫米松市場的主要參與者之企業簡介。
藉由該報告提供的洞察，將能幫助營銷人員和公司高管能夠就未來的產品發布、類型升級、市場擴張和營銷策略做出明智的決策。
全球糠酸莫米松市場報告配合該行業的各種利益相關者，包括投資者、供應商、產品製造商、分銷商、新進入者和金融分析師。
利益相關者可以透過全球糠酸莫米松市場用於分析的各種戰略矩陣來幫助他們更容易做下決策。

企業簡介
- Cipla.
- Teva Pharmaceuticals
- Glenmark Pharmaceuticals
- AdvaCare Pharma
- Medlab Pharmaceuticals Private Limited
- Dermocare Laboratories
- Iva Healthcare Private Limited
- Unilab Chemicals & Pharmaceuticals Pvt Ltd
- Organon group of companies
- Cosette Pharmaceuticals
- Taro Pharmaceutical Industries Ltd.
- Hikma Pharmaceuticals.
分析師的見解

第11章章節

調查手法
關於出版社
諮詢方式

簡介目錄

Product Code: CMI5198

Mometasone furoate topical is effective at reducing the redness, itching, swelling, and other pain caused by several skin conditions. Mometasone furoate is a corticosteroid drug also used to treat asthma and it is an effective treatment for a variety of skin allergies as well as other allergic conditions like hay fever and allergic rhinitis.

Market Dynamics

Increasing prevalence of asthma worldwide is expected to witness significant growth in forecast period. For instance, according to the World Health Organization (WHO), in 2019, 455 000 individuals died from asthma and an estimated 262 million people were affected by asthma worldwide. Asthma is widely misdiagnosed and poorly managed, particularly in low- and middle-income countries. In most severe cases, asthma can be fatal.

Increasing product launches and approvals by market players are expected to drive growth of the global mometasone furoate market over the forecast period. For instance, in April 2017, Amneal Pharmaceuticals LLC, a U.S.-based, publicly traded generics and specialty pharmaceutical company launched Mometasone furoate nasal spray, the first pharmaceutical product that Amneal Pharmaceuticals LLC had produced in spray form. Nasonex is therapeutic equivalent of mometasone furoate and is offered in 50 mcg/spray strength.

Increasing research and development activities related to mometasone furoate are expected to drive growth of market over the forecast period. For instance, according to an article published in Medicine, medical journal, in December 2019, a study was performed on patients with head and neck squamous cell carcinoma (HNSCC) to check efficacy of local application of mometasone furoate in reducing acute radiation dermatitis (ARD) in China. Patients were divided into two groups, test groups and control groups. The patients in test groups were given mometasone furoate once daily from the start of their radiotherapy until the test side skin acquired ARD lesions, and patients in control groups, were given no treatment at all. The study showed that, mometasone furoate inunction after high dose radiotherapy can prevent acute radiation dermatitis (ARD).

Key features of the study:

This report provides an in-depth analysis of the global mometasone furoate market, market size (US$ Million), and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains an attractive investment proposition matrix for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
It profiles leading players in the global mometasone furoate market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans.
Key companies covered as a part of this study include include Cipla, Teva Pharmaceuticals, Glenmark Pharmaceuticals, AdvaCare Pharma, Medlab Pharmaceuticals Private Limited, Dermocare Laboratories, Iva Healthcare Private Limited, Unilab Chemicals & Pharmaceuticals Pvt Ltd, Organon group of companies, Cosette Pharmaceuticals, Taro Pharmaceutical Industries Ltd., and Hikma Pharmaceuticals
Insights from this report would allow marketers and the management authorities of the companies to make an informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics.
The global mometasone furoate market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global mometasone furoate market

Detailed Segmentation:

Global Mometasone Furoate Market, By Dosage form:
- Nasal Spray
- Cream
- Ointment
- Inhalers
- Others (Topical Solutions, etc.)
Global Mometasone Furoate Market, By Indication:
- Inflammatory Skin Disorders
- Asthma
- Allergic rhinitis
- Others (Hay Fever, etc.)
Global Mometasone Furoate Market, By Route of Administration:
- Nasal Administration
- Topical
- Oral
Global Mometasone Furoate Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Mometasone Furoate Market, By Region:
- North America
  - By Country:
- U.S.
- Canada
- Latin America
  - By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
  - By Country:
- U.K.
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- Asia Pacific
  - By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
  - By Country:
- GCC
- Israel
- Rest of Middle East
- Africa
  - By Country/Region:
- South Africa
- Central Africa
- North Africa
Company Profiles
- Cipla *
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
- Teva Pharmaceuticals
- Glenmark Pharmaceuticals
- AdvaCare Pharma
- Medlab Pharmaceuticals Private Limited
- Dermocare Laboratories
- Iva Healthcare Private Limited
- Unilab Chemicals & Pharmaceuticals Pvt Ltd
- Organon group of companies
- Cosette Pharmaceuticals
- Taro Pharmaceutical Industries Ltd.
- Hikma Pharmaceuticals.

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Dosage form
- Market Snippet, By Indication
- Market Snippet, By Route of Administration
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Porter's Analysis
Industry Trends
Key Highlights
Epidemiology
Reimbursement Scenario
Regulatory Scenario
Product Launch and Approvals
Acquisition and Collaboration Scenario

4. Global Mometasone Furoate Market - Impact of Coronavirus (Covid-19) Pandemic

COVID-19 Epidemiology
Impact of COVID-19 on Demand and Supply of Mometasone furoate
Impact of COVID-19 on the Overall Healthcare Sector

5. Global Mometasone Furoate Market , By Dosage Form, 2017-2030 (US$ Million)

Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017-2030
- Segment Trends
Nasal spray
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Cream
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Ointment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Inhalers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global Mometasone Furoate Market , By Indication, 2017-2030 (US$ Million)

Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017-2030
- Segment Trends
Inflammatory skin disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Asthma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Allergic rhinitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Mometasone Furoate Market , By Route of Administration , 2017-2030 (US$ Million)

Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017-2030
- Segment Trends
Nasal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

8. Global Mometasone Furoate Market , By Distribution Channel, 2017-2030 (US$ Million)

Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017-2030
- Segment Trends
Hospitals Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

9. Global Mometasone Furoate Market , By Region, 2017-2030 (US$ Million)

Introduction
- Market Share Analysis, By Region, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2017-2030
- Regional Trends
North America
- Market Size and Forecast, By Dosage Form, 2017-2030 (US$ Mn)
- Market Size and Forecast, By Indication, 2017-2030 (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2017-2030 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017-2030 (US$ Mn)
- Market Size and Forecast, By Country, 2017-2030 (US$ Mn)
U.S.
Canada
Latin America
- Market Size and Forecast, By Dosage Form, 2017-2030 (US$ Mn)
- Market Size and Forecast, By Indication, 2017-2030 (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2017-2030 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017-2030 (US$ Mn)
- Market Size and Forecast, By Country, 2017-2030 (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Market Size and Forecast, By Dosage Form, 2017-2030 (US$ Mn)
- Market Size and Forecast, By Indication, 2017-2030 (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2017-2030 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017-2030 (US$ Mn)
- Market Size and Forecast, By Country, 2017-2030 (US$ Mn)
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
- Market Size and Forecast, By Dosage Form, 2017-2030 (US$ Mn)
- Market Size and Forecast, By Indication, 2017-2030 (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2017-2030 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017-2030 (US$ Mn)
- Market Size and Forecast, By Country, 2017-2030 (US$ Mn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
- Market Size and Forecast, By Dosage Form, 2017-2030 (US$ Mn)
- Market Size and Forecast, By Indication, 2017-2030 (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2017-2030 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017-2030 (US$ Mn)
- Market Size and Forecast, By Country, 2017-2030 (US$ Mn)
GCC
Israel
Rest of Middle East
Africa
- Market Size and Forecast, By Dosage Form, 2017-2030 (US$ Mn)
- Market Size and Forecast, By Indication, 2017-2030 (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2017-2030 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017-2030 (US$ Mn)
- Market Size and Forecast, By Country/Region, 2017-2030 (US$ Mn)
South Africa
Central Africa
North Africa

10. Competitive Landscape

Company Profiles
- Cipla.*
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Strategies
- Teva Pharmaceuticals
- Glenmark Pharmaceuticals
- AdvaCare Pharma
- Medlab Pharmaceuticals Private Limited
- Dermocare Laboratories
- Iva Healthcare Private Limited
- Unilab Chemicals & Pharmaceuticals Pvt Ltd
- Organon group of companies
- Cosette Pharmaceuticals
- Taro Pharmaceutical Industries Ltd.
- Hikma Pharmaceuticals.